drugset / Trial / NCT04351373

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

NCT04351373

Phase 2 Completed 12 enrolled Mayo Clinic
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to see if there is benefit to using an IV contrast called AK-Fluor® and a microscope filter called YELLOW560 when surgically removing a vestibular schwannoma, Meningioma, Head and Neck Paraganglioma, or Head and Neck Schwannoma.

Timeline

Start
2021-10-06
Primary completion
2022-05-25
Completion
2022-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein Diagnostic / imaging agent 1 mg/kg Intravenous

Indications